Respiratory tract infections: an update on the complexity of bacterial diversity, therapeutic interventions and...

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Computational Biology

Background:

• Respiratory tract infections (RTIs) pose a significant global health burden, particularly for vulnerable populations like children and the elderly.
• Key bacterial pathogens including Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae, Staphylococcus aureus, Acinetobacter baumannii, and Pseudomonas aeruginosa are primary causes of RTIs.
• Antimicrobial resistance (AMR) is escalating due to bacterial evolution via horizontal gene transfer and environmental adaptation, leading to treatment failures.

Purpose of the Study:

• To review bacterial virulence mechanisms and pathogenicity in RTIs.
• To highlight therapeutic interventions for combating antimicrobial resistance in respiratory pathogens.
• To explore the application of artificial intelligence (AI) and machine learning (ML) in managing RTIs and addressing the AMR crisis.

Main Methods:

• Literature review focusing on bacterial virulence factors and pathogenicity in RTIs.
• Analysis of current and emerging therapeutic strategies against resistant respiratory pathogens.
• Exploration of AI and ML applications for managing RTIs and combating AMR.

Main Results:

• Identified diverse virulence mechanisms contributing to RTI pathogenicity.
• Highlighted various therapeutic interventions and their potential to overcome antimicrobial resistance.
• Emphasized the role of AI and ML in enhancing the management of RTIs and tackling AMR.

Conclusions:

• Integrative approaches combining mechanistic insights into virulence and novel therapeutics are essential.
• Leveraging AI and ML offers promising avenues for managing RTIs and mitigating the AMR crisis.
• Addressing AMR in respiratory infections requires a multi-faceted strategy encompassing scientific understanding and technological innovation.